IgniteData and RealTime eClinical Solutions Partner to Streamline Clinical Trial Data Transfers Through Archer Platform
IgniteData, a provider of intelligent clinical trial data automation technology, and RealTime eClinical Solutions, a developer of clinical research software, have announced a new partnership designed to simplify clinical data transfers for research sites and clinical trial sponsors. The collaboration will expand access to IgniteData’s Archer platform across RealTime’s network of clinical research sites, enabling secure and efficient transfers of clinical data from RealTime’s electronic source data (eSource) solution directly to sponsors’ electronic data capture (EDC) systems and other designated data destinations.
The partnership aims to address a persistent challenge in clinical research: the time, resources, and administrative effort required to transfer information between systems used by research sites and clinical trial sponsors. By connecting RealTime’s eSource capabilities with Archer’s data-transfer technology, the companies intend to reduce repetitive data entry, streamline research workflows, and help clinical research teams devote more time to patient care and study-related activities.
Clinical trials generate substantial volumes of data that must be collected, transferred, reviewed, and managed across multiple technology platforms. Research sites often work with different systems depending on the requirements of individual sponsors, contract research organizations (CROs), and clinical study protocols. When these systems cannot exchange information efficiently, research personnel may need to perform manual data transfers or enter the same information into multiple applications.
Such processes can increase administrative workloads, create opportunities for transcription errors, and slow the movement of information needed for trial monitoring and oversight. The IgniteData–RealTime partnership is intended to address these operational challenges by enabling clinical data to move from its original electronic source into the sponsor’s preferred destination with less manual intervention.
Under the collaboration, research sites using RealTime’s eSource solution will be able to use Archer to transfer clinical data of any type from the RealTime platform directly to a sponsor’s EDC system or another selected destination. The companies expect this capability to help research organizations improve operational efficiency while supporting sponsors’ efforts to accelerate clinical development.
Connecting eSource Technology With Clinical Trial Data Destinations
The partnership brings together two companies with established positions in the clinical research technology sector. IgniteData focuses on automating clinical trial data transfers, while RealTime eClinical Solutions provides software designed to support the operational needs of clinical research sites, site networks, academic medical centers, health systems, sponsors, and CROs.
RealTime’s electronic source data solution enables research sites to capture information electronically at the point of collection. The integration with Archer is intended to extend the value of this digital workflow by allowing information collected through RealTime’s platform to be transferred directly to the sponsor’s selected system.
Traditionally, clinical research coordinators may need to enter information into an eSource system and then manually transcribe or transfer the same data into a sponsor’s EDC platform. Depending on the study design and the systems involved, this process can require additional checks, follow-up queries, and administrative coordination.
By facilitating a more direct connection between the source system and the sponsor’s data destination, Archer is designed to reduce the need for duplicate data entry. Research personnel can potentially spend less time moving information between applications and more time on activities that directly support trial execution and patient engagement.
The ability to transfer clinical data into different sponsor-selected destinations is also important because clinical research environments are rarely standardized around a single technology platform. Different sponsors may use different EDC systems, while research sites may participate in several studies simultaneously and work with multiple organizations.
IgniteData describes Archer as a platform developed specifically to address longstanding clinical data-transfer challenges. According to the company, Archer is compatible with every data collection tool currently used by sites and sponsors, positioning it as a platform-agnostic solution for organizations operating across diverse clinical technology environments.
This compatibility is intended to reduce the operational friction associated with moving data between systems that may otherwise require separate processes or technology-specific workflows. For research organizations, the approach could simplify coordination across studies and support more consistent data-transfer operations.
Potential Benefits for Research Sites and Trial Sponsors
The companies expect the partnership to deliver operational benefits across the clinical trial ecosystem, particularly for research sites managing multiple studies and sponsors overseeing complex clinical development programs.
For research sites, reducing manual data-transfer activities could help address one of the recurring sources of administrative workload in clinical research. Coordinators and other study personnel are responsible for collecting accurate information, maintaining study documentation, responding to sponsor requests, and supporting protocol-related activities. Repeatedly entering the same information across multiple systems can divert time from these responsibilities.
Through the connection between RealTime eSource and Archer, participating sites will be able to transfer clinical data to sponsors’ designated systems without relying on the same degree of manual re-entry.
Potential benefits for research sites include:
- Reduced duplicate data entry: Electronic transfers can reduce the need to enter the same clinical information into multiple platforms.
- Improved operational efficiency: Streamlined data movement may help research teams manage study workflows with fewer repetitive administrative tasks.
- Lower administrative costs: Reducing manual transfer and associated reconciliation activities could help organizations use staff time and resources more efficiently.
- More time for patient-focused activities: Coordinators may be able to redirect time previously spent on transcription and data-related queries toward patient engagement and other study responsibilities.
- Support for diverse sponsor requirements: Compatibility with different data destinations can help sites manage studies involving multiple sponsors and technology systems.
For sponsors, more efficient data transfers could help reduce delays associated with collecting and reviewing study information. Clinical development programs depend on timely access to reliable data to support monitoring, quality oversight, and other research activities.
When data-transfer processes are slow or labor-intensive, sponsors and CROs may need to devote additional resources to administrative coordination and follow-up. A more automated approach could help reduce these burdens and allow clinical development teams to focus resources on activities that directly advance research objectives.
The companies also believe that streamlined data operations may contribute to shorter clinical development timelines. By reducing avoidable administrative work, the partnership could help sponsors manage study resources more efficiently and potentially shorten the time required to advance a development program toward commercialization.
However, the extent of these benefits will depend on factors such as the systems involved, study requirements, implementation, data-quality controls, and the workflows adopted by individual research organizations.
IgniteData Expands Its Clinical Research Technology Network
IgniteData has positioned Archer as a specialized solution for clinical trial data automation, with a focus on addressing data-transfer challenges experienced by research sites and sponsors.
The company reports that it is engaged with 80% of National Cancer Institute-designated cancer centers, including 19 of the top 30 cancer centers in the United States. Its site network extends across four continents, six countries, and 11 international institutions. IgniteData also reports a 100% retention rate among its partners.
These figures reflect the company’s focus on establishing relationships with research institutions and expanding the use of its technology across clinical research environments.
The partnership with RealTime represents another step in that strategy. By extending Archer’s availability through an established clinical research software provider, IgniteData aims to make its data-transfer capabilities accessible to a broader network of sites already using digital tools to manage study operations and source data.
Laura Hilty, Chief Strategy Officer of IgniteData, described the agreement as an important development in the company’s efforts to improve the efficiency of clinical research.
“Our partnership with RealTime is a meaningful step forward in our mission to help clinical research sites of all types and in all geographies work with sponsors to advance clinical trial research more quickly and efficiently,” Hilty said.
She emphasized Archer’s platform-agnostic approach and its role in reducing the workload associated with transferring clinical data between systems.
“As the only true platform-agnostic technology commercially available today, Archer is playing a unique role in reducing the burden that executing laborious and cumbersome clinical data transfer processes can have on sites and helping to accelerate the pace by which promising discoveries can become new treatments,” she added.
Hilty also highlighted RealTime’s position in the eSource market, noting that the partnership builds on relationships IgniteData has established with technology providers in the clinical research sector. The broader objective is to help sponsors gain access to better data more quickly and improve the efficiency of clinical trial operations.
RealTime Strengthens Its Digital Site Operations Capabilities
RealTime eClinical Solutions provides clinical research software intended to support site operations and study management across a broad range of research organizations. The company reports that its solutions support more than 3,000 sites in over 30 countries.
Its customer base includes major site networks, academic medical centers, health systems, sponsors, and CROs. RealTime reports that its comprehensive Site Operations Management System (SOMS) is used by nine of the 10 largest site networks, three of the five largest CROs, and three of the world’s most trusted hospitals.
The collaboration with IgniteData extends RealTime’s digital workflow capabilities by connecting electronic source data collection with downstream clinical trial data destinations.
The underlying principle is that information should be captured electronically at the source and transferred efficiently to the systems that need it, rather than repeatedly entered by research personnel.
Jeff Kozloff, Chief Executive Officer of RealTime eClinical Solutions, said the partnership is intended to eliminate unnecessary duplication in clinical data workflows.
“Our sites capture data once, electronically, at the source,” Kozloff said. “They shouldn’t have to re-enter it into every sponsor’s EDC. With Archer, data flows from RealTime eSource directly to the sponsor’s system of choice, so coordinators spend less time on transcription and queries and more time with patients.”
Kozloff’s comments underscore the importance of connecting data collection and data management systems as clinical research becomes increasingly dependent on digital infrastructure.
For sites participating in multiple trials, the ability to transfer data efficiently could be particularly valuable. Instead of managing separate manual processes for each sponsor, research organizations may be able to use a more consistent workflow for moving information from the source platform to the appropriate destination.
This approach could also support broader efforts to reduce operational complexity in clinical research, where technology fragmentation can create challenges for both research personnel and sponsor organizations.
Data Security, Quality, and Interoperability Remain Important
The companies have positioned the partnership around secure and efficient clinical data transfers. As clinical research organizations exchange sensitive study information across multiple systems, data security, access controls, and appropriate handling procedures remain essential considerations.
Automating data movement can reduce some risks associated with manual transcription, but the quality and reliability of transferred information still depend on appropriate system configuration, validation, and oversight.
Research sites and sponsors must continue to meet applicable requirements for clinical data integrity, privacy, and study documentation. The practical value of an automated transfer solution will therefore depend not only on connectivity but also on how effectively it supports the controls and procedures required for individual trials.
Compatibility across different systems is another important consideration. A platform designed to work with multiple data collection tools and sponsor destinations may help organizations reduce the need for separate integration processes. Nevertheless, the details of each implementation, including supported destinations and study-specific requirements, will determine how the technology performs in practice.
The IgniteData–RealTime collaboration reflects the wider movement toward more connected clinical research systems. As trials become more data-intensive and research organizations increasingly adopt electronic workflows, improving interoperability between systems is becoming an important part of clinical operations modernization.
Joint Demonstration Planned at SCRS Global Site Solutions Summit 2026
Representatives from IgniteData and RealTime eClinical Solutions will attend the Society for Clinical Research Sites (SCRS) Global Site Solutions Summit, scheduled for October 15–18, 2026, in Orlando, Florida.
The companies plan to demonstrate their joint clinical trial data capabilities and connections during the event. Attendees can visit booth 501 to learn more about the partnership and how Archer can connect RealTime’s eSource platform with sponsors’ preferred data destinations.
The summit will provide an opportunity for clinical research site professionals and other industry participants to learn about the companies’ approach to reducing manual data-transfer activities and improving connections across clinical research technology systems.
The collaboration comes as research organizations continue to seek ways to manage growing administrative demands while maintaining data quality and supporting efficient study execution.
By combining RealTime’s electronic source data capabilities with IgniteData’s Archer platform, the companies aim to simplify the movement of clinical information between research sites and sponsors. If implemented effectively, the partnership could help reduce repetitive work, improve the efficiency of clinical data workflows, and allow research teams to devote more attention to patients and essential trial activities.
Ultimately, the agreement highlights the growing importance of interoperability and automation in clinical development. Although the impact on study timelines and costs will depend on implementation and individual trial requirements, the partnership is intended to address a practical operational challenge that affects sites, sponsors, and CROs across the clinical research industry.
About IgniteData
IgniteData is on a mission to revolutionize clinical trials through intelligent automation. By enabling real-time, secure transfer of clinical data between sites and sponsors, IgniteData accelerates research while reducing burden on clinical sites. IgniteData’s Archer is a 100% agnostic technology that allows for deployments across premier research centers and top pharmaceutical sponsors. By minimizing manual errors, reducing data discrepancies, and limiting downstream queries, IgniteData’s Archer improves data quality, accelerates study timelines, and allows teams to focus on advancing research and delivering better patient outcomes faster.
About RealTime eClinical Solutions
RealTime eClinical Solutions provides cloud-based technology for the organizations that plan, manage, and execute clinical trials. Its Site Operations Management System (SOMS) brings together CTMS, Devana, eSource, eReg/eISF, participant engagement, payments, and analytics to support more connected clinical research operations across sites, site networks, and healthcare organizations. RealTime also provides solutions for sponsors and CROs designed to improve collaboration, data visibility, and trial execution across the research ecosystem.